A new method to help determine whether a +Tg/-Dx scan patient with differentiated thyroid cancer may benefit from a dosimetrically-guided I-131 therapy.
Citation: Unpublished 2017/04/01Department: Medicine/Endocrinology | Medicine/Nuclear MedicineForm of publication: Poster PresentationYear: 20172016Conference information: MedStar Health Research Institute: Endocrine Society Annual Meeting (ENDO 2017), Orlando, FL., Fiscal year: FY2017/FY2017/Local accession number: A2017_315Date added to catalog: 2018-08-01Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Poster Presentation | MedStar Authors Catalog | Poster | Available |